Update
$Phio Pharmaceuticals(PHIO.US$ Phio Pharmaceuticals Announces Positive Recommendation From Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762
newsfile· 5 mins ago
Intratumoral PH-762 has encouraging safety profile in the initial cohort
Escalation to proceed to next dose concentration
newsfile· 5 mins ago
Intratumoral PH-762 has encouraging safety profile in the initial cohort
Escalation to proceed to next dose concentration
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
